Five areas of Newport with poor air quality see improvements
A new report shows the reasons for sustained fall in nitrogen dioxide (NO2) levels along the M4 motorway are 'not entirely clear' to the local authority.
But it has suggested Covid-era restrictions and changes to working and commuting patterns 'will almost certainly have contributed' to the decrease within five of the city's 11 Air Quality Management Areas (AQMAs).
It said the growth in use of low- and zero-emissions vehicles is also likely to have made a positive impact.
The council is now proposing to revoke those five AQMAs, found at five locations along the M4, near Bassaleg Road, Denbigh Road, Glasllwch Crescent, Malpas Road and Royal Oak Hill.
Concentrations of NO2 in those areas have remained below air quality standard limits since at least 2019, according to the council report.
In light of this 'continued compliance', the council is expected to launch separate consultations on the future of each AQMA later this year.
If any or all of the AQMAs are removed, national guidelines recommend the local authority 'should ideally put in place a local or regional air quality strategy to ensure air quality remains a high-profile issue and conditions are prevented from deteriorating in future'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Western Telegraph
3 hours ago
- Western Telegraph
Hayscastle Cross housing approved after five-year wait
In an application recommended for approval at the June meeting of Pembrokeshire County Council's planning committee, Mr and Mrs Down sought permission for a hybrid application for the erection of one dwelling, along with outline permission for two more on land east of Ty Gwyn (Y Bwthyn), Hayscastle Cross, near Haverfordwest. The scheme had been brought to committee as it was recommended for approval despite being contrary to the authority's development plan, a sticking point being a small part being outside the settlement boundary. The scheme includes a commuted sum contribution to affordable housing, in the case of Hayscastle Cross set at 10 per cent, of the development value, amounting to £15,262.50. Affordable housing contributions in the county vary from as low as five per cent in Fishguard and Pembroke Dock to as high as 25 per cent in towns like Narberth. Five letters of objection raised concerns including drainage, traffic generation, housing need, flooding and it being a linear development. An officer report concluded: 'The proposal would result in residential development over a small area of the countryside location in conflict with the requirements [of policies]. However, the minimal area of land involved and the ability it provides to facilitate development of the site are material considerations which outweigh the identified policy conflicts.' Speaking at the meeting, agent Andrew Vaughan-Harries of Hayston Developments & Planning Ltd said he was 'shocked at the time' that had passed since the application was first lodged some five years ago. He said the scheme had faced 'a lot of hurdles' since it was submitted, including the Covid-19 pandemic, delays over addressing phosphate concerns and there being a nearby SSSI. He said the scheme, with its £15,000 affordable housing contribution, would 'enhance this little bit of Haycastle Cross'. The application was moved by Cllr Brian Hall, with new committee chair Cllr Mark Carter, whose own ward is nearby, saying: 'This to me, is just a natural progression of the village which has expanded over the years; it's just joining the rest of the row.' The application was unanimously approved by committee members.
South Wales Argus
7 hours ago
- South Wales Argus
Covid NB.1.8.1 cases rising: what is known about new variant
Covid NB.1.8.1 is a variation of the XDV.1.5.1 strain and was first detected back in January 2025. However, reports of the new variant are "growing rapidly", according to the World Health Organisation (WHO), and it is showing some signs of "additional immune evasion" compared to others. World Health Organisation monitoring COVID NB.1.8.1 The WHO has placed the Covid NB.1.8.1 "under monitoring" due to the rise in cases worldwide. It is one of six COVID-19 variants currently being monitored. The new 'Strategic and operational plan for coronavirus disease threat management: at a glance' sets out the global framework for supporting Member States in the sustained, integrated, evidence-based management of coronavirus disease threats, including #COVID19, MERS, and… — World Health Organization (WHO) (@WHO) May 28, 2025 However, the WHO stated that the risk posed by the new variant was "low," and that approved COVID-19 vaccines are expected to be effective against it. The world health experts, in a recent risk evaluation, said: "Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation. The WHO added: "The available evidence on NB.1.8.1 does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages." Where has Covid NB.1.8.1 been detected? COVID NB.1.8.1 has already been detected in 22 countries. These include the likes of Australia, China, Hong Kong, Thailand and the US, according to The Independent. The coming COVID-19 Winter Surge in Australia will show the world where we are actually headed is happening in South-Eats Asia and East Asia are just the 'preludes'...watch how NB.1.8.1 spawns are evolving including PQ.1, PQ.2 and even sub-lineages like PE.1. — Thailand Medical News (@ThailandMedicaX) June 4, 2025 COVID NB.1.8.1 in the UK Cases of the NB.1.8.1 variant have also been confirmed in Northern Ireland, Wales, and "popular British tourist hotspots", the news outlet added. What are the symptoms of COVID-19? Health organisations are yet to list any symptoms unique to Covid NB.1.8.1. However, common symptoms of other COVID-19 variants, according to the NHS, include: High temperature or shivering (chills) New, continuous cough (this means coughing a lot for more than an hour, or three or more coughing episodes in 24 hours) Loss or change to your sense of smell or taste Shortness of breath Feeling tired or exhausted Aching body Headache Sore throat Blocked or runny nose Loss of appetite Diarrhoea Feeling sick or being sick How to tell if you have a cold, the flu or COVID-19 How to protect yourself from COVID-19 variants COVID-19 vaccines are available in the UK, and are usually offered on the NHS in spring and early winter. The vaccine is available for those: Aged 75 or over (including those who will be 75 by 17 June, 2025) Aged 6 months to 74 years and have a weakened immune system because of a health condition or treatment Live in a care home for older adults RECOMMENDED READING: The NHS said: "The COVID-19 vaccines are offered because viruses change and protection fades over time. It's important to top up your protection if you're eligible." The vaccine helps: Reduce your risk of getting severe symptoms Recover more quickly if you catch COVID-19 Reduce your risk of having to go to hospital or dying from COVID-19 Protect against different types of COVID-19 virus Eligible people can book in for a vaccination via the NHS website, the NHS App, or by attending a walk-in COVID-19 vaccination site.
Glasgow Times
8 hours ago
- Glasgow Times
Number of people with ADHD ‘probably isn't increasing that much'
Experts said that while there has been a rise in people being diagnosed with ADHD in the UK, the exact number is 'still probably lower than the best estimates' of the true number who have the condition. An increase in patients seeking assessments could possibly be down to greater awareness and less stigma, or disruption caused by the Covid-19 pandemic. Researchers also suggest spending a lot of time online could be creating a 'distracted generation', but that it is too early to draw conclusions. And while there is a link between social media and ADHD symptoms it is unclear 'what's driving what'. ADHD assessments are reported to be increasingly in demand, researchers said, which is putting a strain on health and education systems across the world. People with the neuro-developmental disorder may have trouble concentrating or sitting still, while other symptoms include being easily distracted, forgetfulness, finding it hard to follow instructions or organise time, and making impulsive decisions. Earlier this month, NHS England estimated for the first time that 2,498,000 people in England may have ADHD, which includes those without a diagnosis. Of the total, an estimated 741,000 are children and young people aged five to 24. And more than half a million people (549,000) were waiting for an ADHD assessment at the end of March 2025, up from 416,000 a year earlier, according to figures. The study, led by King's College London, aimed to update reviews on ADHD prevalence by examining global research from 2020 onwards. Academics looked at more than 9,000 studies, with 40 from across 17 different countries – one of which included data from 42 countries – included in the final analysis. Professor Philip Shaw, director of the King's Maudsley Partnership for Children and Young People at KCL's institute of psychiatry, psychology and neuroscience, said: 'It seems that our best evidence suggests that the true rate of ADHD probably isn't increasing that much. 'However, it's absolutely crystal clear that there is an increase in the number of people who are being clinically recognised or diagnosed as having ADHD in the United Kingdom. 'However, I will note that that rate is still probably lower than the best estimates we have of the rate of true ADHD in the population.' Dr Alex Martin, a lecturer in psychology and pandemic preparedness at KCL's institute of psychiatry, psychology and neuroscience, added: 'What we did find was that ADHD prevalence in adults and children has remained largely stable since 2020.' She said that some data being published is 'very much out of date', adding: 'This causes problems for healthcare policy makers internationally and means that services which are already under pressure may encounter increased demand without receiving additional support. According to Prof Shaw, the health service is 'playing catch-up' when it comes to ADHD, which he said could explain 'a marked uptick in the numbers of people seeking assessment'. Edmund Sonuga-Barke, a professor of developmental psychology, psychiatry and neuroscience at KCL, added there has been 'chronic under-recognition' in the history of ADHD, especially for certain groups and in particular women and girls. 'So part of the increase in diagnosis we've seen over the last 10 or so years is really a resetting or a recalibration, or a catch-up,' he said. Prof Shaw added: 'When I was at medical school and training as a psychiatrist, there was actually very little recognition of ADHD, particularly in young people and adults. 'Of course, there's both an increased recognition and – very welcome – less stigma around ADHD, which means that people are increasingly coming forward for assessment, and while we're working through that backlog, there are simply going to be long waiting lists.' Some other possibilities which Prof Shaw described as 'somewhat less likely' include a change in the threshold of how doctors diagnose ADHD and a shift in the understanding of the condition by children and young people. He added that his 'hunch' is that the 'huge awareness' of ADHD is 'that it's often used as a language of distress'. 'It's sometimes used, I suspect, the way that children and young people are expressing that they are struggling, particularly at school, and need help,' he said 'And of course, when a child is having problems that are impacting their life in a sustained way, they deserve a full mental health assessment. 'Even if the final diagnosis doesn't end up being ADHD, we may often, for example, find that this child is struggling with a problem with mood or anxiety.' Other societal issues could be driving the increase in assessments, including the disruption caused by the Covid-19 pandemic and the use of social media. Prof Shaw said: 'Many of the skills of learning that kids have, how to focus, how to plan, how to organise themselves, has completely throw them out the loop for about two or three years, and this may well play a part in the uptick in the awareness and seeking of help for symptoms of inattention in particular. 'Many also point to a possible role for social media and the impacts it might be having on the developing brain. 'Now, for ADHD, there's a great degree of interest in the possibility that what's going on, is that the constant dividing of attention and multitasking online is creating, if you like, a distracted generation. 'We know there's an association between social media use and some symptoms of ADHD, but we don't know what's driving what, we don't know what's the chicken and what's the egg.' Prof Shaw said he has been 'struck' by some of his group's research findings into how 'variable' ADHD can be. He suggests ADHD 'is a dynamic challenge that changes with age'. Prof Sonuga-Barke added: 'I think the discovery that ADHD is a continuous risk dimension and not a fixed, natural category with clear biological boundaries may help explain why diagnostic rates are sensitive to changes in cultural values and beliefs, and clinical practices, and environmental risk exposures.'
